Publications
Journal of Epidemiology — Februay 04, 2023
SARS‑CoV‑2 elicits non‑sterilizing immunity and evades vaccine‑induced immunity: implications for future vaccination strategies.
A new article from Leyden Labs has been published in the European Journal of Epidemiology, titled "SARS‑CoV‑2 elicits non‑sterilizing immunity and evades vaccine‑induced immunity: implications for future vaccination strategies.”
Frontiers in Virology — November 02, 2022
The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection
Recently, our article entitled “The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection,” appeared in a special issue of Frontiers in Virology on the role of genetic and structural insights of neutralizing antibodies to guide viral vaccine design.
Infectious Diseases & Therapy — October 30, 2022
Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community
A new research article by Leyden Labs and partners at Imperial College has been published in Infectious Diseases & Therapy.
OUR NEW APPROACH | OUR TEAM | JOIN OUR MISSION | NEWS | CAREERS
Leyden Laboratories B.V.
Leiden Laboratory
Emmy Noetherweg 2
2333 BK Leiden
The Netherlands
Leyden Laboratories Co.
Boston Laboratory
201 Dexter Avenue
Watertown
MA 02472
United States
Leyden Labs S.L.
Granada Office
Avda. del Conocimiento 41.A210
Centro de Empresas
Parque Tecnológico de la Salud
18016 Granada
Spain
© Leyden Labs, 2023 | Privacy Policy | Design by Ape to Zebra
